Study of LJP 394 in Lupus Patients With History of Renal Disease (ASPEN)

This study has been terminated.
(Interim efficacy analysis indicated it would be futile to continue study.)
Information provided by:
La Jolla Pharmaceutical Company Identifier:
First received: August 13, 2004
Last updated: March 30, 2009
Last verified: March 2009
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2009
  Primary Completion Date: February 2009 (Final data collection date for primary outcome measure)